Pepscan Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients (NCT00895466) | Pepscan Therapeutics | 2008-10-01 |
Track Pepscan Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.